Safety of Moxifloxacin following repeated intramuscular administration in Wistar rats
Moxifloxacin is a novel fourth generation fluoroquinolone with broad spectrum of antibacterial activity. The study was conducted to evaluate the safety of Moxifloxacin (5.0 mg/kg) after repeated intramuscular administration at 24 h interval for 14 days in male and female wistar rats. Hematological (...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Veterinary World
2010-01-01
|
| Series: | Veterinary World |
| Subjects: | |
| Online Access: | http://www.scopemed.org/mnstemps/2/2-1286564526.pdf |